Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 52% ± 21% | |
lung | 7 studies | 27% ± 10% | |
eye | 6 studies | 52% ± 18% | |
heart | 4 studies | 34% ± 4% | |
adipose | 4 studies | 28% ± 8% | |
kidney | 4 studies | 22% ± 6% | |
peripheral blood | 3 studies | 24% ± 2% | |
liver | 3 studies | 35% ± 11% | |
intestine | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3413.25 | 1445 / 1445 | 100% | 17.14 | 183 / 183 |
brain | 100% | 3873.72 | 2634 / 2642 | 100% | 14.79 | 704 / 705 |
intestine | 100% | 7049.95 | 966 / 966 | 99% | 17.25 | 521 / 527 |
stomach | 100% | 2878.49 | 359 / 359 | 98% | 16.64 | 281 / 286 |
breast | 100% | 4190.06 | 459 / 459 | 98% | 14.85 | 1091 / 1118 |
lung | 100% | 4544.63 | 577 / 578 | 97% | 9.78 | 1123 / 1155 |
prostate | 100% | 2885.33 | 245 / 245 | 97% | 10.48 | 485 / 502 |
bladder | 100% | 3373.67 | 21 / 21 | 96% | 11.02 | 485 / 504 |
kidney | 100% | 2268.73 | 89 / 89 | 96% | 11.93 | 863 / 901 |
uterus | 100% | 3616.53 | 170 / 170 | 95% | 9.50 | 436 / 459 |
thymus | 100% | 3103.82 | 652 / 653 | 95% | 7.67 | 575 / 605 |
pancreas | 96% | 1677.58 | 315 / 328 | 98% | 11.04 | 174 / 178 |
skin | 100% | 4152.50 | 1809 / 1809 | 92% | 9.92 | 432 / 472 |
adrenal gland | 100% | 2825.84 | 258 / 258 | 90% | 6.85 | 208 / 230 |
ovary | 100% | 2581.29 | 180 / 180 | 82% | 5.04 | 352 / 430 |
liver | 94% | 1138.02 | 212 / 226 | 47% | 2.51 | 190 / 406 |
adipose | 100% | 4283.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5911.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.35 | 29 / 29 |
spleen | 100% | 4064.18 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.10 | 1 / 1 |
heart | 99% | 2361.97 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1822.02 | 793 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 11.45 | 42 / 45 |
peripheral blood | 80% | 2372.97 | 744 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 6.91 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000902 | Biological process | cell morphogenesis |
GO_0031175 | Biological process | neuron projection development |
GO_0030427 | Cellular component | site of polarized growth |
GO_0005938 | Cellular component | cell cortex |
Gene name | FRYL |
Protein name | Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) FRY like transcription coactivator |
Synonyms | AF4P12 KIAA0826 |
Description | FUNCTION: Plays a key role in maintaining the integrity of polarized cell extensions during morphogenesis, regulates the actin cytoskeleton and plays a key role in patterning sensory neuron dendritic fields by promoting avoidance between homologous dendrites as well as by limiting dendritic branching (By similarity). May function as a transcriptional activator. . |
Accessions | A0A286YEZ9 O94915 A0A2C9F2R7 ENST00000358350.9 [O94915-1] ENST00000505759.1 ENST00000503238.6 A0A669KB90 A0A6E1XQM6 D6R9B9 F2Z2S2 ENST00000507711.5 ENST00000641795.1 ENST00000507873.8 ENST00000514617.5 H0Y9X0 ENST00000673760.1 |